Efficacy and Safety of Dupilumab Maintained in Adults >= 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials (vol 24, pg 469, 2023)

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY(2023)

引用 2|浏览12
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要